The role of cardiovascular pharmacology and therapeutics extends far beyond traditional drug regimens, encompassing groundbreaking treatments that address the intricate mechanisms of heart diseases. Recent developments include RNA-based therapies and regenerative drugs designed to repair cardiac tissue at a molecular level. Researchers are also investigating the role of anti-inflammatory agents in reducing atherosclerosis progression. Clinical trials for novel anticoagulants and lipid-lowering medications continue to refine strategies for preventing thrombotic events and improving long-term patient health. This dynamic field integrates pharmacological advances with patient-specific approaches to enhance both the efficacy and safety of cardiovascular care.
Title : Complete heart block and persistent left SVC: A pacing challenge after AV canal repair
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia
Title : Chemical detergent anionic surfactant-inducing dry cardiomyopathy (Yasser's cardiomyopathy) with parallel pupils/CXR phenomenon (Yasser's ophthalmic phenomenon), up-down Yasser's alternance, S1Q3 flat T3 pattern - Dramatic response to honey with possible cardiac regeneration - A case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Stabilization of molecular structures in red blood cell membrane by magnetite nanoparticles (ICNB) during storage
Andrey Belousov, Laboratory of Applied Nanotechnology of Belousov and Kharkiv National Medical University, Ukraine